Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 270

1.

Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future.

Godman B, Basu D, Pillay Y, Mwita JC, Rwegerera GM, Anand Paramadhas BD, Tiroyakgosi C, Okwen PM, Niba LL, Nonvignon J, Sefah I, Oluka M, Guantai AN, Kibuule D, Kalemeera F, Mubita M, Fadare J, Ogunleye OO, Distiller LA, Rampamba EM, Wing J, Mueller D, Alfadl A, Amu AA, Matsebula Z, Kalungia A, Zaranyika T, Masuka N, Wale J, Hill R, Kurdi A, Timoney A, Campbell S, Meyer JC.

Front Pharmacol. 2020 Mar 20;11:108. doi: 10.3389/fphar.2020.00108. eCollection 2020. Review.

PMID:
32265688
2.

Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries.

Godman B, McCabe H, D Leong T, Mueller D, Martin AP, Hoxha I, Mwita JC, Rwegerera GM, Massele A, Costa JO, do Nascimento RCRM, Lemos LLP, Tachkov K, Milushewa P, Patrick O, Niba LL, Laius O, Sefah I, Abdulsalim S, Soleymani F, Guantai AN, Achieng L, Oluka M, Jakupi A, Logviss K, Hassali MA, Kibuule D, Kalemeera F, Mubita M, Fadare J, Ogunleye OO, Saleem Z, Hussain S, Bochenek T, Mardare I, Alrasheedy AA, Furst J, Tomek D, Markovic-Pekovic V, Rampamba EM, Alfadl A, Amu AA, Matsebula Z, Phuong TNT, Thanh BN, Chichonyi Kalungia A, Zaranyika T, Masuka N, Olaru ID, Wale J, Hill R, Kurdi A, Timoney A, Campbell S, Meyer JC.

Expert Rev Pharmacoecon Outcomes Res. 2020 Apr 1:1-26. doi: 10.1080/14737167.2020.1734456. [Epub ahead of print]

PMID:
32237953
3.

Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia.

Kibuule D, Aiases P, Ruswa N, Rennie TW, Verbeeck RK, Godman B, Mubita M.

ERJ Open Res. 2020 Mar 16;6(1). pii: 00030-2019. doi: 10.1183/23120541.00030-2019. eCollection 2020 Jan.

4.

Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future.

Godman B, Basu D, Pillay Y, Almeida PHRF, Mwita JC, Rwegerera GM, Anand Paramadhas BD, Tiroyakgosi C, Patrick O, Niba LL, Sefah I, Oluka M, Guantai AN, Kibuule D, Kalemeera F, Mubita M, Fadare J, Ogunleye OO, Rampamba EM, Wing J, Mueller D, Alfadl A, Amu AA, Matsebula Z, Kalungia A, Zaranyika T, Masuka N, Wale J, Hill R, Kurdi A, Timoney A, Campbell S, Meyer JC.

Hosp Pract (1995). 2020 Mar 20. doi: 10.1080/21548331.2020.1745509. [Epub ahead of print]

PMID:
32196395
5.

Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions.

Gad M, Salem A, Oortwijn W, Hill R, Godman B.

Front Pharmacol. 2020 Mar 3;11:144. doi: 10.3389/fphar.2020.00144. eCollection 2020.

6.

Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications.

Modisakeng C, Matlala M, Godman B, Meyer JC.

BMC Health Serv Res. 2020 Mar 19;20(1):234. doi: 10.1186/s12913-020-05080-1.

7.

Effectiveness of Maintenance Immunosuppression Therapies in a Matched-Pair Analysis Cohort of 16 Years of Renal Transplant in the Brazilian National Health System.

Gomes RM, Barbosa WB, Godman B, Costa JO, Ribeiro Junior NG, Simão Filho C, Cherchiglia ML, Acurcio FA, Guerra Júnior AA.

Int J Environ Res Public Health. 2020 Mar 17;17(6). pii: E1974. doi: 10.3390/ijerph17061974.

8.

Statin prescription among patients with type 2 diabetes in Botswana: findings and implications.

Mwita JC, Godman B, Esterhuizen TM.

BMC Endocr Disord. 2020 Mar 10;20(1):36. doi: 10.1186/s12902-020-0516-7.

9.

Antimicrobial dispensing practices and determinants of antimicrobial resistance: a qualitative study among community pharmacists in Pakistan.

Saleem Z, Hassali MA, Hashmi FK, Godman B, Saleem F.

Fam Med Community Health. 2019 Jul 12;7(3):e000138. doi: 10.1136/fmch-2019-000138. eCollection 2019.

10.

Nature and sources of poisoning in patients admitted to a referral hospital in Gaborone, Botswana; findings and implications.

Mbongwe B, Moinami J, Masupe T, Tapera R, Molefe T, Erick P, Godman B, Massele A.

Hosp Pract (1995). 2020 Mar 26:1-8. doi: 10.1080/21548331.2020.1739415. [Epub ahead of print]

PMID:
32133895
11.

Assessment of antimicrobial use and prescribing practices among pediatric inpatients in Zimbabwe.

Olaru ID, Meierkord A, Godman B, Ngwenya C, Fitzgerald F, Dondo V, Ferrand RA, Kranzer K.

J Chemother. 2020 Mar 2:1-4. doi: 10.1080/1120009X.2020.1734719. [Epub ahead of print]

PMID:
32114964
12.

Profiles of patients on warfarin anticoagulation therapy in a leading tertiary referral hospital in Kenya; findings and implications for Kenya.

Nyamu DG, Guantai AN, Osanjo GO, Godman B, Aklillu E.

Expert Rev Cardiovasc Ther. 2020 Mar 2:1-9. doi: 10.1080/14779072.2020.1734452. [Epub ahead of print]

PMID:
32090626
13.

Drug utilization review of tramadol hydrochloride in a regional hospital in South Africa; findings and implications.

Fynn A, Helberg E, Godman B, Meyer JC.

Hosp Pract (1995). 2020 Mar 11:1-8. doi: 10.1080/21548331.2020.1724454. [Epub ahead of print]

PMID:
32013641
14.

Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study.

Acurcio FA, Guerra Junior AA, da Silva MRR, Pereira RG, Godman B, Bennie M, Nedjar H, Rahme E.

Curr Med Res Opin. 2020 Apr;36(4):677-686. doi: 10.1080/03007995.2020.1722945. Epub 2020 Feb 11.

PMID:
31990224
15.

Prevalence of Self-Medication for Acute Respiratory Infections in Young Children in Namibia: Findings and Implications.

Kamati M, Godman B, Kibuule D.

J Res Pharm Pract. 2019 Dec 27;8(4):220-224. doi: 10.4103/jrpp.JRPP_19_121. eCollection 2019 Oct-Dec.

16.

Empowering Hypertensive Patients in South Africa to Improve Their Disease Management: A Pharmacist-Led Intervention.

Rampamba EM, Meyer JC, Helberg EA, Godman B.

J Res Pharm Pract. 2019 Dec 27;8(4):208-213. doi: 10.4103/jrpp.JRPP_18_74. eCollection 2019 Oct-Dec.

17.

Availability and Use of Therapeutic Interchange Policies in Managing Antimicrobial Shortages among South African Public Sector Hospitals; Findings and Implications.

Chigome AK, Matlala M, Godman B, Meyer JC.

Antibiotics (Basel). 2019 Dec 20;9(1). pii: E4. doi: 10.3390/antibiotics9010004.

18.

Implications of antibiotic exposure among children in low-income and middle-income countries.

Olaru ID, Kibuule D, Godman B.

Lancet Infect Dis. 2020 Feb;20(2):146-147. doi: 10.1016/S1473-3099(19)30681-4. Epub 2019 Dec 13. No abstract available.

PMID:
31843382
19.

The impact of law enforcement on dispensing antibiotics without prescription: a multi-methods study from Saudi Arabia.

Alrasheedy AA, Alsalloum MA, Almuqbil FA, Almuzaini MA, Aba Alkhayl BS, Albishri AS, Alharbi FF, Alharbi SR, Alodhayb AK, Alfadl AA, Godman B, Hill R, Anaam MS.

Expert Rev Anti Infect Ther. 2020 Jan;18(1):87-97. doi: 10.1080/14787210.2020.1705156. Epub 2019 Dec 23.

PMID:
31834825
20.

An evidence-based framework for identifying technologies of no or low-added value (NLVT).

Esandi ME, Gutiérrez-Ibarluzea I, Ibargoyen-Roteta N, Godman B.

Int J Technol Assess Health Care. 2020;36(1):50-57. doi: 10.1017/S0266462319000734. Epub 2019 Dec 13.

PMID:
31831086
21.

Effect of TDF-containing regimens on creatinine clearance in HIV patients in Namibia with a baseline CrCl <60ml/min; findings and implications.

Kalemeera F, Godman B, Stergachis A, Rennie T.

Hosp Pract (1995). 2020 Feb;48(1):35-40. doi: 10.1080/21548331.2020.1703438. Epub 2020 Jan 14.

PMID:
31829065
22.

Consumer willingness to pay for a hypothetical chikungunya vaccine in Brazil and the implications.

Sarmento TTR, Godói IP, Reis EA, Godman B, Ruas CM.

Expert Rev Pharmacoecon Outcomes Res. 2019 Dec 12:1-8. doi: 10.1080/14737167.2020.1703181. [Epub ahead of print]

PMID:
31815561
23.

Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future.

Godman B, Haque M, McKimm J, Abu Bakar M, Sneddon J, Wale J, Campbell S, Martin AP, Hoxha I, Abilova V, Anand Paramadhas BD, Mpinda-Joseph P, Matome M, de Lemos LLP, Sefah I, Kurdi A, Opanga S, Jakupi A, Saleem Z, Hassali MA, Kibuule D, Fadare J, Bochenek T, Rothe C, Furst J, Markovic-Pekovic V, Bojanić L, Schellack N, Meyer JC, Matsebula Z, Phuong TNT, Thanh BN, Jan S, Kalungia A, Mtapuri-Zinyowera S, Sartelli M, Hill R.

Curr Med Res Opin. 2020 Feb;36(2):301-327. doi: 10.1080/03007995.2019.1700947. Epub 2019 Dec 30.

PMID:
31794332
24.

Isoniazid acetylation phenotypes in the Sudanese population; findings and implications.

Ali MH, Alrasheedy AA, Kibuule D, Hassali MA, Godman B, Abdelwahab MF, Abbadi RY.

J Clin Tuberc Other Mycobact Dis. 2019 Sep 6;17:100120. doi: 10.1016/j.jctube.2019.100120. eCollection 2019 Dec.

25.

Pattern of inappropriate antibiotic use among hospitalized patients in Pakistan: a longitudinal surveillance and implications.

Saleem Z, Saeed H, Hassali MA, Godman B, Asif U, Yousaf M, Ahmed Z, Riaz H, Raza SA.

Antimicrob Resist Infect Control. 2019 Nov 21;8:188. doi: 10.1186/s13756-019-0649-5. eCollection 2019.

26.

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries.

Godman B, Grobler C, Van-De-Lisle M, Wale J, Barbosa WB, Massele A, Opondo P, Petrova G, Tachkov K, Sefah I, Abdulsalim S, Alrasheedy AA, Unnikrishnan MK, Garuoliene K, Bamitale K, Kibuule D, Kalemeera F, Fadare J, Khan TA, Hussain S, Bochenek T, Kalungia AC, Mwanza J, Martin AP, Hill R, Barbui C.

Expert Opin Pharmacother. 2019 Dec;20(18):2237-2255. doi: 10.1080/14656566.2019.1684473. Review.

27.

Antibiotic Prescribing Patterns at a Leading Referral Hospital in Kenya: A Point Prevalence Survey.

Momanyi L, Opanga S, Nyamu D, Oluka M, Kurdi A, Godman B.

J Res Pharm Pract. 2019 Oct 16;8(3):149-154. doi: 10.4103/jrpp.JRPP_18_68. eCollection 2019 Jul-Sep.

28.

Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab.

Pontes C, Zara C, Torrent-Farnell J, Obach M, Nadal C, Vella-Bonanno P, Ermisch M, Simoens S, Hauegen RC, Gulbinovic J, Timoney A, Martin AP, Mueller T, Nachtnebel A, Campbell S, Selke G, Bochenek T, Rothe CC, Mardare I, Bennie M, Fürst J, Malmstrom RE, Godman B.

Appl Health Econ Health Policy. 2020 Feb;18(1):5-16. doi: 10.1007/s40258-019-00527-x.

PMID:
31696433
29.

Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications.

Ali MH, Alrasheedy AA, Kibuule D, Godman B, Hassali MA, Ali HMH.

Expert Rev Anti Infect Ther. 2019 Nov;17(11):927-937. doi: 10.1080/14787210.2019.1689818. Epub 2019 Nov 18.

30.

Adjustments of medication dosages in patients with renal impairment in Botswana; findings and implications to improve patient care.

Sheikh AM, Rwegerera GM, Godman B, Habte D.

Hosp Pract (1995). 2019 Dec;47(5):231-240. doi: 10.1080/21548331.2019.1685800. Epub 2019 Nov 14.

PMID:
31662005
31.

Stage at diagnosis and stage-specific survival of breast cancer in Latin America and the Caribbean: A systematic review and meta-analysis.

de Lemos LLP, Carvalho de Souza M, Pena Moreira D, Ribeiro Fernandes Almeida PH, Godman B, Verguet S, Guerra AA Junior, Leal Cherchiglia M.

PLoS One. 2019 Oct 16;14(10):e0224012. doi: 10.1371/journal.pone.0224012. eCollection 2019.

32.

Implications of non-prescription antibiotic sales in China.

Kalungia A, Godman B.

Lancet Infect Dis. 2019 Dec;19(12):1272-1273. doi: 10.1016/S1473-3099(19)30408-6. Epub 2019 Oct 3. No abstract available.

PMID:
31588041
33.

Antimicrobial utilization research and activities in Botswana, the past, present and the future.

Tiroyakgosi C, Matome M, Kgatlwane J, Anand Paramadhas BD, Malone B, Mpinda-Joseph P, Rwegerera GM, Maika K, Mashalla Y, Godman B, Massele A.

Expert Rev Anti Infect Ther. 2019 Oct;17(10):759-762. doi: 10.1080/14787210.2019.1668777. Epub 2019 Sep 23.

34.

Indicator of access to medicines in relation to the multiple dimensions of access.

Garcia MM, Barbosa MM, Silva RM, Reis EA, Alvares J, Assis Acurcio F, Godman B, Guerra Junior AA.

J Comp Eff Res. 2019 Sep;8(12):1027-1041. doi: 10.2217/cer-2019-0031. Epub 2019 Sep 12.

PMID:
31512925
35.

Discontinuation, persistence and adherence to subcutaneous biologics delivered via a homecare route to Scottish adults with rheumatic diseases: a retrospective study.

Alvarez-Madrazo S, Kavanagh K, Siebert S, Semple Y, Godman B, Maciel Almeida A, Acurcio FA, Bennie M.

BMJ Open. 2019 Sep 4;9(9):e027059. doi: 10.1136/bmjopen-2018-027059.

36.

Proactive risk assessment of vincristine use process in a teaching and referral hospital in Kenya and the implications.

Kurgat EK, Weru I, Wata D, Godman B, Kurdi A, Guantai AN.

J Oncol Pharm Pract. 2020 Apr;26(3):666-679. doi: 10.1177/1078155219869439. Epub 2019 Sep 2.

37.

The use of probiotics as a supplementary therapy in the treatment of patients with asthma: a pilot study and implications.

Moura JCV, Moura ICG, Gaspar GR, Mendes GMS, Faria BAV, Jentzsch NS, do Carmo Friche Passos M, Kurdi A, Godman B, Almeida AM.

Clinics (Sao Paulo). 2019;74:e950. doi: 10.6061/clinics/2019/e950. Epub 2019 Aug 12.

38.

Snapshot of antimicrobial stewardship programs in the hospitals of Pakistan: findings and implications.

Saleem Z, Hassali MA, Hashmi FK, Godman B, Ahmed Z.

Heliyon. 2019 Jul 25;5(7):e02159. doi: 10.1016/j.heliyon.2019.e02159. eCollection 2019 Jul.

39.

Medicine Shortages: Gaps Between Countries and Global Perspectives.

Acosta A, Vanegas EP, Rovira J, Godman B, Bochenek T.

Front Pharmacol. 2019 Jul 19;10:763. doi: 10.3389/fphar.2019.00763. eCollection 2019.

40.

Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India.

Abdulsalim S, Unnikrishnan MK, Manu MK, Alsahali S, Alrasheedy AA, Martin AP, Godman B, Alfadl AA.

Pharmacoecon Open. 2019 Jul 31. doi: 10.1007/s41669-019-0172-x. [Epub ahead of print]

41.

Healthcare-associated infections including neonatal bloodstream infections in a leading tertiary hospital in Botswana.

Mpinda-Joseph P, Anand Paramadhas BD, Reyes G, Maruatona MB, Chise M, Monokwane-Thupiso BB, Souda S, Tiroyakgosi C, Godman B.

Hosp Pract (1995). 2019 Oct;47(4):203-210. doi: 10.1080/21548331.2019.1650608. Epub 2019 Aug 27.

42.

Glycaemic, blood pressure and low-density lipoprotein-cholesterol control among patients with diabetes mellitus in a specialised clinic in Botswana: a cross-sectional study.

Mwita JC, Francis JM, Omech B, Botsile E, Oyewo A, Mokgwathi M, Molefe-Baikai OJ, Godman B, Tshikuka JG.

BMJ Open. 2019 Jul 23;9(7):e026807. doi: 10.1136/bmjopen-2018-026807.

43.

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan.

Ali MH, Alrasheedy AA, Hassali MA, Kibuule D, Godman B.

Antibiotics (Basel). 2019 Jul 9;8(3). pii: E90. doi: 10.3390/antibiotics8030090.

44.

Antimicrobial prescribing and determinants of antimicrobial resistance: a qualitative study among physicians in Pakistan.

Saleem Z, Hassali MA, Godman B, Hashmi FK, Saleem F.

Int J Clin Pharm. 2019 Oct;41(5):1348-1358. doi: 10.1007/s11096-019-00875-7. Epub 2019 Jul 4.

PMID:
31273588
45.

Essential and forgotten antibiotics: An inventory in low- and middle-income countries.

Tebano G, Li G, Beovic B, Bielicki J, Brink A, Enani MA, Godman B, Hinrichsen SL, Kibuule D, Gabriel LH, Oduyebo O, Sharland M, Singh S, Wertheim HFL, Nathwani D, Pulcini C; European Society of Clinical Microbiology and Infectious Diseases Study Group for Antimicrobial Stewardship.

Int J Antimicrob Agents. 2019 Sep;54(3):273-282. doi: 10.1016/j.ijantimicag.2019.06.017. Epub 2019 Jun 28.

PMID:
31260741
46.

Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications.

Anand Paramadhas BD, Tiroyakgosi C, Mpinda-Joseph P, Morokotso M, Matome M, Sinkala F, Gaolebe M, Malone B, Molosiwa E, Shanmugam MG, Raseatlholo GP, Masilo J, Oyeniran Y, Marumoloa S, Maakelo OG, Katjakae I, Kgatlwane J, Godman B, Massele A.

Expert Rev Anti Infect Ther. 2019 Jul;17(7):535-546. doi: 10.1080/14787210.2019.1629288. Epub 2019 Jul 1.

PMID:
31257952
47.

Correction to: A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa.

Makhele L, Matlala M, Sibanda M, Martin AP, Godman B.

Pharmacoecon Open. 2019 Dec;3(4):647. doi: 10.1007/s41669-019-0151-2.

48.

Point prevalence surveys of health-care-associated infections: a systematic review.

Saleem Z, Godman B, Hassali MA, Hashmi FK, Azhar F, Rehman IU.

Pathog Glob Health. 2019 Jun;113(4):191-205. doi: 10.1080/20477724.2019.1632070. Epub 2019 Jun 19.

PMID:
31215326
49.

Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications.

McCabe H, Godman B, Kurdi A, Johnston K, MacBride-Stewart S, Lennon J, Hurding S, Bennie M, Morton A.

Expert Rev Respir Med. 2019 Jul;13(7):679-689. doi: 10.1080/17476348.2019.1624528. Epub 2019 Jun 12.

50.

A repeated point prevalence survey of antimicrobial use in specialized cancer care hospital of Pakistan: findings and implications.

Saleem Z, Hassali MA, Hashmi FK, Godman B, Bhutta OA.

Hosp Pract (1995). 2019 Aug;47(3):149-154. doi: 10.1080/21548331.2019.1628614. Epub 2019 Jun 27.

PMID:
31180791

Supplemental Content

Loading ...
Support Center